Charming Medical MCTA
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 6th percentile, 5-year average 239.1x
Near the bottom of its 5-year range · 11th percentile, 5-year average 5,659.1x
#5271 of 5311 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 100th percentile, 5-year average 46.2x
#4926 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 86.09 | – | 5,659.12 | 11% (cheaper than usual) | #5271 of 5311 (1 = cheapest) |
| PE | -29,355.00 | – | 239.12 | 6% (cheaper than usual) | – |
| PS | 92.67 | – | 46.22 | 100% (pricier than usual) | #4926 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on MCTA.
Sign in to join the discussion.